The various facets of the protein‐folding activity of the ribosome
- 12 May 2011
- journal article
- review article
- Published by Wiley in Biotechnology Journal
- Vol. 6 (6) , 668-673
Abstract
In addition to its involvement in protein synthesis, the ribosome is implicated in protein folding. Some co‐translational events, such as the rhythm of protein synthesis, the passage through the exit tunnel of the ribosome, or the interaction with ribosome‐associated chaperones may help protein folding. Ribosomes from prokaryotes, eukaryotes, and mitochondria have also been shown to assist the folding of denatured proteins in vitro in a translation‐independent way. This intriguing protein‐folding activity of the ribosome (PFAR, also termed RPFA) has been mapped to the domain V of the large rRNA of the large subunit of the ribosome. Unfolded, newly synthesized proteins catalyze the dissociation of the two ribosomal subunits in vitro, thereby promoting ribosome recycling and facilitating accessibility of domain V to these proteins, which in turn may help their folding by PFAR. The recent identification of 6AP and GA – the two first drugs that specifically inhibit PFAR without affecting protein translation – will help decipher the biological significance of PFAR in vivo. Of note, 6AP and GA were initially isolated on the basis of their activity against prion‐based diseases. Recently, 6AP and GA were also shown to be active in vivo in a drosophila model for oculopharyngeal muscular dystrophy, which is another amyloid‐based disease. This effect is mimicked by large deletions in the ribosomal DNA (rDNA) locus. In addition, small deletions in the rDNA locus show a synergistic effect with low doses of 6AP and GA. Hence, PFAR may be involved in various amyloid‐based diseases.Keywords
This publication has 36 references indexed in Scilit:
- Ligand-Driven Vectorial Folding of Ribosome-Bound Human CFTR NBD1Molecular Cell, 2011
- Antiprion drugs 6‐aminophenanthridine and guanabenz reduce PABPN1 toxicity and aggregation in oculopharyngeal muscular dystrophyEMBO Molecular Medicine, 2011
- The Origins of Cellular LifeCold Spring Harbor Perspectives in Biology, 2010
- Cotranslational structure acquisition of nascent polypeptides monitored by NMR spectroscopyProceedings of the National Academy of Sciences, 2010
- Probing ribosome-nascent chain complexes produced in vivo by NMR spectroscopyProceedings of the National Academy of Sciences, 2009
- Altering the ribosomal subunit ratio in yeast maximizes recombinant protein yieldMicrobial Cell Factories, 2009
- Protein Solubility and Folding Enhancement by Interaction with RNAPLOS ONE, 2008
- Protein Folding Activity of Ribosomal RNA Is a Selective Target of Two Unrelated Antiprion DrugsPLOS ONE, 2008
- Protein Folding by Domain V of Escherichia coli 23S rRNA: Specificity of RNA-Protein InteractionsJournal of Bacteriology, 2008
- Antihypertensive Drug Guanabenz Is Active In Vivo against both Yeast and Mammalian PrionsPLOS ONE, 2008